Calidi Biotherapeutics, Inc
Price
FilingsNewest: 8-K, Listing noticeSep 25 →InsidersNo open-market buys. 1 insider sold $1,241 in 1 sale, with no 10b5-1 plan named.→Financing →PeersClosest companies: CMPX, NXTC, RLYB→
From the filings
Figures
- Net income
- −$17.5Mlast 12 months
- Operating cash flow
- −$18.3Mlast 12 months
- Cash and equivalents
- $4.3Mat the last balance sheet
- Total debt
- $645,000at the last balance sheet
- Shares outstanding
- 2.1M shareson issue